XERS logo

Xeris Biopharma Holdings, Inc. (XERS)

Profile

Full Name

Xeris Biopharma Holdings, Inc.

Ticker

NASDAQ: XERS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 21, 2018

Indexes

Not included

Website

https://www.xerispharma.com

Employees

394

Key Details

Price

$7.68(-1.66%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$203.07M(+23.89% YoY)

Annual EPS

-$0.37(+17.78% YoY)

PE ratio

-

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.68
    XERS price is $7.68

    30-Day Relative Volume

    0.41
    XERS 30-day relative volume is 0.41

    Price Performance

    Price Most recent change

    -1.66%
    XERS price was down -1.66% on Sep 11, 2025

    Price YTD change

    +126.55%
    XERS price is up +126.55% since January 1st

    Price 1-year change

    +168.53%
    XERS price is up +168.53% year-on-year

    Price 3-year change

    +321.98%
    XERS price is up +321.98% over the past 3 years

    Price Range

    Price All-time high

    $27.98
    XERS price is currently -72.55% below its historical high of $27.98

    Price 3-year low

    $0.97
    XERS price is currently +691.75% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.24B
    XERS market capitalization is $1.24 billion

    Market cap 3-year change

    +401.2%
    XERS market capitalization is up +401.2% over the past 3 years

    Market cap All-time high

    $1.29B
    XERS market capitalization is currently -3.88% below its historical high of $1.29 billion

    Market cap sector rank

    75.21%
    XERS market capitalization is higher than 75.21% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +8.38%
    XERS shares outstanding is up +8.38% year-on-year

    Shares Outstanding 3-Year Change

    +18.77%
    XERS shares outstanding is up +18.77% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.91
    XERS beta is 0.91

    200-day SMA

    $4.71
    XERS price is currently +63.20% above its 200-day simple moving average

    50-day SMA

    $6.37
    XERS price is currently +20.57% above its 50-day simple moving average

    RSI

    62.53
    XERS 14-day relative strength index is 62.53

    Volume

    0.41
    XERS 30-day relative volume is 0.41

    ATR

    $0.28
    XERS average true range is $0.28

    10-day Historical Volatility

    17.99%
    XERS 10-day historical volatility is 17.99%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $203.07M
    XERS annual revenue is $203.07 million

    Revenue Analysts estimate

    $286.47M
    XERS annual revenue is currently -29.11% lower than the consensus analysts' forecast

    Revenue 1-year change

    +23.89%
    XERS annual revenue is up +23.89% year-on-year

    Revenue Sector rank

    74.19%
    XERS annual revenue is higher than 74.19% of companies in Healthcare sector

    EPS

    EPS

    -$0.37
    XERS annual earnings per share is -$0.37

    EPS Analysts estimate

    -$0.01
    XERS annual earnings per share is currently +3600.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +17.78%
    XERS annual earnings per share is up +17.78% year-on-year

    EPS Sector rank

    66.11%
    XERS annual earnings per share is higher than 66.11% of companies in Healthcare sector

    Profit

    Gross profit

    $166.24M
    XERS annual gross profit is $166.24 million

    Gross margin

    76.52%
    XERS annual gross profit margin is 76.52%

    Operating profit

    -$33.65M
    XERS annual operating income is -$33.65 million

    Operating margin

    -16.57%
    XERS annual operating profit margin is -16.57%

    Net income

    -$54.84M
    XERS annual net profit is -$54.84 million

    Net margin

    -27.00%
    XERS annual net profit margin is -27.00%

    Expenses

    Total expenses

    $236.72M
    XERS annual total expenses is $236.72 million

    Operating expenses

    $199.88M
    XERS annual total operating expenses is $199.88 million

    Cost of goods sold

    $47.67M
    XERS annual cost of goods sold is $47.67 million

    Selling, general & administrative expenses

    $163.48M
    XERS annual SGA is $163.48 million

    Depreciation and amortization

    $12.63M
    XERS annual depreciation & amortization is $12.63 million

    Interest expense

    $30.48M
    XERS annual interest expense is $30.48 million

    Income tax

    -$2.27M
    XERS annual income tax is -$2.27 million

    EBIT & EBITDA

    EBIT

    -$26.62M
    XERS annual earnings before interest & taxes is -$26.62 million

    EBITDA

    -$13.99M
    XERS annual EBITDA is -$13.99 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $329.15M
    XERS annual total assets is $329.15 million

    Non current assets

    $155.40M
    XERS annual long term assets is $155.40 million

    Current assets

    $167.66M
    XERS annual total current assets is $167.66 million

    Cash and cash equivalents

    $71.62M
    XERS annual cash & cash equivalents is $71.62 million

    Accounts receivable

    $40.41M
    XERS annual accounts receivable is $40.41 million

    Inventory

    $48.17M
    XERS annual inventory is $48.17 million

    Liabilities

    Total liabilities

    $358.77M
    XERS annual total liabilities is $358.77 million

    Long term liabilities

    $252.23M
    XERS annual total long term liabilities is $252.23 million

    Current liabilities

    $100.44M
    XERS annual total current liabilities is $100.44 million

    Accounts payable

    $2.29M
    XERS annual accounts payable is $2.29 million

    Debt

    Total debt

    $271.45M
    XERS annual total debt is $271.45 million

    Total debt 1-year change

    +18.44%
    XERS annual total debt is up +18.44% year-on-year

    Long term debt

    $250.26M
    XERS annual long term debt is $250.26 million

    Short term debt

    $21.18M
    XERS annual short term debt is $21.18 million

    Equity & Capital

    Shareholders equity

    -$29.61M
    XERS annual stockholders equity is -$29.61 million

    Book value

    -$29.61M
    XERS annual book value is -$29.61 million

    Retained earnings

    -$671.86M
    XERS annual retained earnings is -$671.86 million

    Working capital

    $67.22M
    XERS annual working capital is $67.22 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$36.98M
    XERS annual cash flow from operations is -$36.98 million

    Cash from operations 1-year change

    +21.36%
    XERS annual cash flow from operations is up +21.36% year-on-year

    Cash from investing

    $4.88M
    XERS annual cash flow from investing activities is $4.88 million

    Cash from investing 1-year change

    +181.33%
    XERS annual cash flow from investing activities is up +181.33% year-on-year

    Cash from financing

    $36.17M
    XERS annual cash flow from financing activities is $36.17 million

    Cash from financing 1-year change

    +2342.28%
    XERS annual cash flow from financing activities is up +2342.28% year-on-year

    CAPEX

    CAPEX

    $868.00K
    XERS annual capital expenditures is $868.00 thousand

    CAPEX 1-year change

    -61.64%
    XERS annual capital expenditures is down -61.64% year-on-year

    Free Cash Flow

    Free cash flow

    -$37.85M
    XERS annual free cash flow is -$37.85 million

    Free cash flow 1-year change

    +23.21%
    XERS annual free cash flow is up +23.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    76.52%
    XERS annual gross profit margin is 76.52%

    Operating margin

    -16.57%
    XERS annual operating profit margin is -16.57%

    Net margin

    -27.00%
    XERS annual net profit margin is -27.00%

    ROA & ROE

    ROA

    -16.37%
    XERS annual return on assets is -16.37%

    ROE

    185.16%
    XERS annual return on equity is 185.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    XERS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    XERS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -64.25
    XERS price to book ratio is -64.25

    PB ratio Sector rank

    1.35%
    XERS price to book ratio is higher than 1.35% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.04
    XERS price to sales ratio is 5.04

    PS ratio Sector rank

    57.44%
    XERS price to sales ratio is higher than 57.44% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.44B
    XERS enterprise value is $1.44 billion

    Enterprise value Sector rank

    77.01%
    XERS enterprise value is higher than 77.01% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    194.52
    XERS EV/EBITDA is 194.52

    EV/EBITDA Sector rank

    99.19%
    XERS EV/EBITDA is higher than 99.19% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.67
    XERS annual current ratio is 1.67

    Quick ratio

    1.19
    XERS annual quick ratio is 1.19

    Leverage

    Debt to equity

    -7.84
    XERS annual debt to equity ratio is -7.84

    Interest coverage ratio

    -0.87
    XERS annual interest coverage ratio is -0.87

    Risk & Stability

    Piotroski F-Score

    4
    XERS piotroski f-score is 4

    Altman Z-Score

    -0.19
    XERS altman z-score is -0.19

    Analyst ratings

    Recent major analysts updates

    Aug 19, 25 Leerink Partners
    Outperform
    Aug 8, 25 Oppenheimer
    Outperform
    Aug 8, 25 Craig-Hallum
    Buy
    May 9, 25 Oppenheimer
    Outperform
    Mar 7, 25 Piper Sandler
    Neutral
    Mar 7, 25 Leerink Partners
    Outperform
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 Craig-Hallum
    Buy
    Jan 29, 25 Jefferies
    Buy
    Nov 11, 24 Piper Sandler
    Neutral

    Institutional Ownership

    Screeners with XERS included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Stocks ready to break out
    Healthcare sector
    All stocks
    • What is the ticker symbol for Xeris Biopharma Holdings, Inc.?
    • Does Xeris Biopharma Holdings, Inc. pay dividends?
    • What sector is Xeris Biopharma Holdings, Inc. in?
    • What industry is Xeris Biopharma Holdings, Inc. in?
    • What country is Xeris Biopharma Holdings, Inc. based in?
    • When did Xeris Biopharma Holdings, Inc. go public?
    • Is Xeris Biopharma Holdings, Inc. in the S&P 500?
    • Is Xeris Biopharma Holdings, Inc. in the NASDAQ 100?
    • Is Xeris Biopharma Holdings, Inc. in the Dow Jones?
    • When was Xeris Biopharma Holdings, Inc.'s last earnings report?
    • When does Xeris Biopharma Holdings, Inc. report earnings?

    What is the ticker symbol for Xeris Biopharma Holdings, Inc.?

    The ticker symbol for Xeris Biopharma Holdings, Inc. is NASDAQ:XERS

    Does Xeris Biopharma Holdings, Inc. pay dividends?

    No, Xeris Biopharma Holdings, Inc. does not pay dividends

    What sector is Xeris Biopharma Holdings, Inc. in?

    Xeris Biopharma Holdings, Inc. is in the Healthcare sector

    What industry is Xeris Biopharma Holdings, Inc. in?

    Xeris Biopharma Holdings, Inc. is in the Biotechnology industry

    What country is Xeris Biopharma Holdings, Inc. based in?

    Xeris Biopharma Holdings, Inc. is headquartered in United States

    When did Xeris Biopharma Holdings, Inc. go public?

    Xeris Biopharma Holdings, Inc.'s initial public offering (IPO) was on June 21, 2018

    Is Xeris Biopharma Holdings, Inc. in the S&P 500?

    No, Xeris Biopharma Holdings, Inc. is not included in the S&P 500 index

    Is Xeris Biopharma Holdings, Inc. in the NASDAQ 100?

    No, Xeris Biopharma Holdings, Inc. is not included in the NASDAQ 100 index

    Is Xeris Biopharma Holdings, Inc. in the Dow Jones?

    No, Xeris Biopharma Holdings, Inc. is not included in the Dow Jones index

    When was Xeris Biopharma Holdings, Inc.'s last earnings report?

    Xeris Biopharma Holdings, Inc.'s most recent earnings report was on August 7, 2025

    When does Xeris Biopharma Holdings, Inc. report earnings?

    The next expected earnings date for Xeris Biopharma Holdings, Inc. is November 7, 2025
    On this page